The COVID-19 pandemic was a worldwide lesson on the importance of flexibility and agility required for today's manufacturers to respond to demands for life-changing therapeutics. Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
Visit us online for key insights from our Biopharma Resilience Index:
www.cytiva.com/resilienceStart planning for your future resilient biomanufacturing capacity needs:
https://cytiva.link/spc1y
